Aethlon Medical, Inc. (AEMD) - Form 8-K Summary
Business Context and Reporting Period
This Form 8-K, dated November 12, 2025, serves as a current report for Aethlon Medical, Inc., a Nevada corporation headquartered in San Diego, California. The filing primarily addresses the disclosure of financial results for the quarter ended September 30, 2025, pursuant to Item 2.02 (Results of Operations and Financial Condition) and Item 7.01 (Regulation FD Disclosure).
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. The document explicitly states that the detailed financial results are contained within a press release furnished as Exhibit 99.1, which is incorporated by reference but not reproduced in the text of this 8-K.
Material Changes
No material changes versus the prior comparable period are detailed in the body of this filing. The report defers all operational and financial comparisons to the referenced press release (Exhibit 99.1).
Guidance, Outlook, and Risks
The filing contains no specific guidance, outlook, management commentary, or risk factors within its text. It includes standard legal disclaimers noting that the information furnished under Item 7.01 is not deemed "filed" for purposes of Section 18 of the Exchange Act and shall not be incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated November 12, 2025) for actual revenue, net income, and cash flow figures for the quarter ended September 30, 2025.
- Verify year-over-year and quarter-over-quarter performance metrics in the referenced press release.
- Confirm the company's liquidity position and cash runway as detailed in the full financial statements or press release.
- Check for any forward-looking statements or updated guidance provided in the press release that are not present in this 8-K summary.